🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Denmark / NCT07044232
Recruiting Phase 4

NICardipine for Fast Achievement of Systolic BP Targets in ICH

NCT07044232 · tracked via the Priya Life Science Denmark tracker
Phase
Phase 4
Started
2025-10-01
Last updated
2026-06-24

Condition(s) studied

Intracerebral Haemorrhage

Investigational drug(s) / intervention(s)

NicardipineGlyceryl trinitrate

Nicardipine: Nicardipine infusion based acute blood pressure lowering treatment

Glyceryl trinitrate: Glyceryltrinitrate based acute blood pressure lowering treatment

Study summary

Quality improvement study with a quasi-randomized design. The study monitors the effect of a gradually implemented treatment algorithm prioritizing intravenous antihypertensives (e.g., nicardipine) over long-acting nitrate patches. It aims to increase the proportion of patients reaching target systolic BP \<140 mmHg within 1 hour of hospital admission while monitoring safety, clinical outcomes, and healthcare resource utilization.

Eligibility

Sex
ALL
Min age
18 Years
Max age
—
Healthy volunteers
No
Inclusion Criteria: * Age ≥18 years * Acute spontaneous Intracerberal Hemorrhage confirmed by imaging * Symptom onset to stroke center admission \<6 hours * Elevated systolic blood pressure (\>140 mmHg) at admission Exclusion Criteria: * Secondary causes of ICH (e.g., trauma, vascular malformation) * Presumed fatal bleeding at admission * Short remaining life expectancy (\<12 month)

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Aarhus University Hospital Aarhus Denmark Recruiting

More Aarhus University Hospital trials in Denmark

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07044232 on ClinicalTrials.gov ↗ ← All trials in Denmark